Drug-eluting stents. A review of the current literature

Cardiol Rev. 2004 Jan-Feb;12(1):37-43. doi: 10.1097/01.crd.0000090893.66550.9d.

Abstract

Coronary interventions have revolutionized the treatment of coronary artery disease (CAD). Stents, which were used initially for the complications arising from coronary angiography gradually, came to occupy a more prominent role in coronary interventions. However, restenosis remained a limiting factor from a therapeutic point of view. Recent development of drug-eluting stents is a step toward overcoming this problem. This development has elicited a great interest in both physician as well as patient communities. We have reviewed the available medical evidence regarding drug-eluting stents.

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease / therapy*
  • Drug Delivery Systems*
  • Humans
  • Paclitaxel / administration & dosage*
  • Prosthesis Design
  • Randomized Controlled Trials as Topic
  • Sirolimus / administration & dosage*
  • Stents*

Substances

  • Paclitaxel
  • Sirolimus